(Q39579127)

13 September 2017

title

Calcitonin treatment of Paget's disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A92633

18 November 2022

author name string

I. M. Evans

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A92633

18 November 2022

language of work or name

English

0 references

publication date

1 December 1979

1 reference

13 September 2017

8 December 1979

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=92633

full work available at URL

18 November 2022

https://api.elsevier.com/content/article/PII:S0140673679923456?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(79)92345-6

https://api.elsevier.com/content/article/PII:S0140673679923456?httpAccept=text/plain

18 November 2022

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(79)92345-6

18 November 2022

1 reference

13 September 2017

volume

2

1 reference

13 September 2017

issue

8154

1 reference

13 September 2017

page(s)

1232-1233

1 reference

Osteoclast ultrastructure in Paget’s disease

13 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2879%2992345-6

7 January 2021

Acute effects of calcitonin on osteoclasts in man

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2879%2992345-6

7 January 2021

Calcitonin Resistance: Clinical and Immunologic Studies in Subjects with Paget's Disease of Bone Treated with Porcine and Salmon Calcitonins

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2879%2992345-6

7 January 2021

An evaluation of antibodies and clinical resistance to salmon calcitonin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2879%2992345-6

7 January 2021

Paget's bone disease: response to human calcitonin in patients resistant to salmon calcitonin.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2879%2992345-6

7 January 2021

Effects of Prolonged Thyrocalcitonin Administration on Paget's Disease of Bone

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2879%2992345-6

7 January 2021

Human calcitonin in the treatment of Paget's bone disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2879%2992345-6

7 January 2021

Response of Paget's disease to porcine and salmon calcitonins: effects of long-term treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2879%2992345-6

7 January 2021

Deafness in Paget's diseases: effect of salmon calcitonin treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2879%2992345-6

7 January 2021

Healing of the bones in juvenile Paget's disease treated by human calcitonin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2879%2992345-6

7 January 2021

Hereditary bone dysplasia with hyperphosphatasaemia: response to synthetic human calcitonin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2879%2992345-6

7 January 2021

Otological Studies in Patients with Deafness Due to Paget's Disease Before and After Treatment with Synthetic Human Calcitonin

series ordinal

20

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(79)92345-6

18 November 2022

Identifiers

1 reference

13 September 2017

1 reference